HIMS vs HNGE vs VRHI Stock Comparison

Hims & Hers Health, Hinge Health and Veri MedTech Holdings Prices as of Nov 16, 2026 Peers: Industry group
HNGE Hinge Health, Inc.
$121.24 +22.2% 1M +196.0% 1Y
Market cap
$9.19B
P/E
55.1x
Revenue (TTM)
$800.82M
Div. yield
–
Telehealth Healthcare
5 wins

Head to Head

7 decided of 12

Hinge Health leads on 5 of the 12 questions below (Hinge Health 5, Veri MedTech Holdings 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionHIMSHNGEVRHILeader
Larger companyMarket capitalisation $4.13B $9.19B $35.28M HNGE
Cheaper on earningsLower P/E, profitable companies only -21.7x 55.1x -17.0x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — 42.9x — –
Faster revenue growthRevenue growth, trailing twelve months +29.8% +49.9% -31.2% HNGE
More profitableNet margin, trailing twelve months -6.6% 20.8% -22.5% HNGE
Better return on capitalReturn on invested capital — — — –
Less leveragedLower net debt / EBITDA — — -0.1x –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% — –
Better 1-year returnPrice return, last 12 months -49.8% +196.0% +221.9% VRHI
Better 5-year returnAnnualised price return, 5 years +18.0%/yr — +33.5%/yr VRHI
Less volatileAnnualised volatility, 1 year 91.2% 51.1% 158.2% HNGE
Higher overall scoreMean of the five percentile scores vs peers 38/100 70/100 21/100 HNGE

Percentile Scorecard

HIMSHNGEVRHI

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisHIMSHNGEVRHI
Valuation 36 #64 of 99 27 #73 of 99 19 #80 of 99
Growth 24 #68 of 89 97 #4 of 89 31 #62 of 89
Profitability 33 #62 of 92 99 #2 of 92 31 #64 of 92
Financial Health 20 #83 of 103 45 #57 of 103 5 #98 of 103
Shareholder Returns 76 #16 of 63 84 #11 of 63 –
Overall 38 70 21
  • HIMS ranked among 103 companies in Healthcare Providers
  • HNGE ranked among 103 companies in Healthcare Providers
  • VRHI ranked among 103 companies in Healthcare Providers

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodHIMSHNGEVRHISPY
1 month -33.9%+22.2%0.0% -3.0%
3 months -35.2%+37.9%+87.7% -4.2%
6 months -16.7%+121.6%+283.5% +0.2%
Year to date -42.8%+161.0%+252.8% +8.5%
1 year -49.8%+196.0%+221.9% +10.1%
3 years +148.5%—+1,160.0% +64.1%
3 years, per year +35.5%—+132.8% +18.0%
5 years +128.6%—+324.0% +58.1%
5 years, per year +18.0%—+33.5% +9.6%
10 years ——+1,060.5% +239.6%
10 years, per year ——+27.8% +13.0%

Risk

MeasureHIMSHNGEVRHISPY
Volatility, 1Y 91.2%51.1%158.2% 13.8%
Downside volatility, 1Y 86.9%47.1%327.7% 14.2%
Beta vs S&P 500, 1Y 2.591.11-0.34 1.00
Return / volatility, 1Y -0.553.841.40 0.74
Max drawdown, 5Y -78.9%-48.5%-87.3% -25.4%
From 52-week high -53.6%-1.6%-26.5% -5.0%
52-week high $40.02$123.17$6.00 $779.14
52-week low $14.52$31.17$0.97 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleHIMSHNGEVRHI
P/E now vs peer median -24.2xmedian 22.4x 56.0xmedian 22.4x -17.0xmedian 22.4x
P/S now vs peer median 1.6xmedian 1.3x 11.7xmedian 1.3x 3.8xmedian 1.3x
EV/EBITDA now vs peer median -33.4xmedian 14.2x 40.0xmedian 14.2x -17.9xmedian 14.2x
P/FCF now vs peer median 145.7xmedian 19.0x 29.1xmedian 19.0x 149.3xmedian 19.0x
P/B now vs peer median 13.0xmedian 2.6x 31.3xmedian 2.6x -12.9xmedian 2.6x
PEG now vs peer median 0.35median 0.84 —median 0.84 —median 0.84

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsHIMSHNGEVRHI
Revenue $2.87B $800.82M $9.21M
Gross profit $1.83B $686.54M $6.94M
Operating income -$232.48M $150.09M -$1.99M
Net income -$190.81M $168.31M -$2.07M
Free cash flow $31.68M $322.00M $236.34K
R&D $212.19M $134.62M –
EPS (diluted) $-0.82 $1.93 –
Cash & equivalents $605.60M $211.55M –
Total debt – – $101.39K
Shares (diluted) 233.82M 86.53M –
Enterprise value $1.25B $7.82B $35.28M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricHIMSHNGEVRHI
P/E -24.2x 56.0x -17.0x
P/FCF 145.7x 29.1x 149.3x
P/Operating cash flow 25.6x 29.0x 149.3x
P/S 1.6x 11.7x 3.8x
P/B 13.0x 31.3x -12.9x
P/Tangible book -110.0x 40.6x -12.9x
EV/EBITDA -33.4x 40.0x -17.9x
EV/EBIT -16.8x 60.5x -17.8x
EV/Revenue 1.4x 11.3x 3.8x
EV/FCF 123.2x 28.2x 149.7x
EV/Operating cash flow 21.7x 28.1x 149.7x
PEG (3Y EPS CAGR) 0.35 – –

Growth

14 metrics
MetricHIMSHNGEVRHI
Revenue growth (1Y) 29.8% 49.9% -31.2%
Revenue CAGR (3Y) 53.6% – –
Gross profit growth (1Y) 10.4% 63.4% -30.5%
Gross profit CAGR (3Y) 41.7% – –
Operating income growth (1Y) -302.1% 127.2% -103.2%
Operating income CAGR (3Y) -78.8% – –
Net income growth (1Y) -242.6% 131.6% -91.6%
Net income CAGR (3Y) -74.8% – –
EPS growth (1Y) -251.7% 135.4% –
EPS CAGR (3Y) -68.7% – –
Operating cash flow growth (1Y) -44.6% 121.4% 660.4%
Operating cash flow CAGR (3Y) 59.0% – –
Free cash flow growth (1Y) -76.3% 121.4% 728.5%
Free cash flow CAGR (3Y) -3.1% – –

Profitability

14 metrics
MetricHIMSHNGEVRHI
Gross margin 63.8% 85.7% 75.3%
EBITDA margin -4.1% 28.3% -21.5%
Operating margin -8.1% 18.7% -21.5%
Pretax margin -7.7% 20.8% -22.1%
Net margin -6.6% 20.8% -22.5%
FCF margin 1.1% 40.2% 2.6%
Operating cash flow margin 6.3% 40.3% 2.6%
Return on equity -65.9% 52.2% –
Return on assets -6.2% 19.7% -1,064%
Return on invested capital – – –
Return on capital employed -10.8% 49.0% –
Asset turnover 0.8x 0.9x 49.2x
Cash conversion (OCF / net income) -0.9x 1.9x -0.1x
Stock comp / revenue 6.2% 8.4% 14.8%

Financial Health

11 metrics
MetricHIMSHNGEVRHI
Debt / assets – – 59.3%
Debt / equity – – 0.0x
Net debt / EBITDA – – -0.1x
Debt / FCF – – 0.4x
Liabilities / assets 90.0% 65.7% 1,698%
Equity / assets 10.0% 34.3% -1,598%
Interest coverage – – -28.9x
Current ratio 0.9x 1.0x 0.0x
Quick ratio 0.8x 0.9x –
Cash ratio 0.5x 0.5x –
Altman Z-score 1.29 9.84 -38.09

Shareholder Returns

7 metrics
MetricHIMSHNGEVRHI
Dividend yield – – –
Net buyback yield 1.3% 2.2% –
Shareholder yield 1.3% 2.2% –
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusHIMSHNGEVRHI
Forward P/E – 42.9xFY2026 –
EPS, next fiscal year $-0.93FY2026 $2.69FY2026 –
EPS growth, next FY -282.4%FY2026 +2.7%FY2026 –
EPS growth, the year after – +20.8% –
Revenue, next fiscal year $3.28BFY2026 $899.57MFY2026 –
Revenue growth, next FY +39.8%FY2026 +53.0%FY2026 –
Revenue growth, the year after +25.4% +29.5% –

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersHIMSHNGEVRHI
Held by institutions 69.3% 92.1% –
Institutions holding 510 279 –
Change in shares held, QoQ +4.4% +2.5% –
Institutions buying 325 198 –
Institutions selling 130 66 –
Buyers to sellers 2.50 3.00 –

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

HIMSHNGEVRHI
HIMS 1.00 0.27 -0.07
HNGE 0.27 1.00 0.08
VRHI -0.07 0.08 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, HIMS, HNGE and VRHI?

Hinge Health (HNGE) is the largest by market capitalisation: Hims & Hers Health (HIMS) $4.13B, Hinge Health (HNGE) $9.19B, Veri MedTech Holdings (VRHI) $35.28M.

Which company is growing faster?

Hinge Health (HNGE) grew revenue fastest over the trailing twelve months: Hims & Hers Health (HIMS) +29.8%, Hinge Health (HNGE) +49.9%, Veri MedTech Holdings (VRHI) -31.2%.

Which company is more profitable?

Hinge Health (HNGE) has the highest net margin (Hims & Hers Health (HIMS) -6.6%, Hinge Health (HNGE) 20.8%, Veri MedTech Holdings (VRHI) -22.5%).

Which stock has performed better?

Over the past year Veri MedTech Holdings (VRHI) returned the most: Hims & Hers Health (HIMS) -49.8%, Hinge Health (HNGE) +196.0%, Veri MedTech Holdings (VRHI) +221.9%. Over five years, Veri MedTech Holdings (VRHI) compounded fastest (Hims & Hers Health (HIMS) +18.0%/yr, Veri MedTech Holdings (VRHI) +33.5%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Hinge Health (HNGE) has been the steadiest (Hims & Hers Health (HIMS) 91.2%, Hinge Health (HNGE) 51.1%, Veri MedTech Holdings (VRHI) 158.2%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, HIMS, HNGE and VRHI?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Hinge Health (HNGE) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.